Endogenous benzodiazepine ligands in human cerebrospinal fluid

Area of Science:

• Neurochemistry
• Pharmacology

Background:

• Human cerebrospinal fluid contains endogenous compounds that may interact with neurotransmitter systems.
• Benzodiazepine receptors are crucial targets for modulating neuronal excitability.

Purpose of the Study:

• To identify and characterize endogenous ligands for benzodiazepine receptors in human cerebrospinal fluid.
• To investigate the chemical nature and activity of these putative ligands.

Main Methods:

• Size exclusion chromatography (Bio-Gel P-4) and high-performance liquid chromatography (HPLC) were used for fractionation.
• Receptor-binding assays with (3H)-diazepam were employed to detect activity.
• Enzymatic digestion and kinetic analysis (Lineweaver-Burke) were performed to characterize active fractions.

Main Results:

• Three distinct peaks free of salt and GABA displaced (3H)-diazepam.
• Two peaks competitively inhibited diazepam binding.
• GABA enhanced the activity of these two peaks.
• Enzymatic treatment suggested a peptide component in the second active peak.

Conclusions:

• Human cerebrospinal fluid contains endogenous benzodiazepine receptor ligands.
• At least one active component is likely a peptide.
• These findings contribute to understanding endogenous neuromodulation of GABAergic systems.